COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,582 Articles (22,415 medRxiv, 8,167 bioRxiv)

Most recent first Previous |  Page 1784: Articles 17831-17840  | Next

A single dose of replication-competent VSV-vectored vaccine expressing SARS-CoV-2 S1 protects against virus replication in a hamster model of severe COVID-19
Malherbe, D. C., Kurup, D., Wirblich, C., Ronk, A. J., Mire, C., Kuzmina, N., Shaik, N., Periasamy, S., Hyde, M. A., Williams, J. M., Shi, P.-Y., Schnell, M. J., Bukreyev, A.
10.1101/2021.01.29.428442 — Posted: 2021-01-30
SARS-CoV-2 binding and neutralizing antibody levels after vaccination with Ad26.COV2.S predict durable protection in rhesus macaques
Roozendaal, R., Solforosi, L., Stieh, D., Serroyen, J., Straetemans, R., Wegmann, F., Rosendahl Huber, S. K., van der Lubbe, J. E. M., Hendriks, J., le Gars, M., Dekking, L., Czapska-Casey, D. N., Guimera, N., Janssen, S., Tete, S., Chandrashekar, A., Mercado, N., Yu, J., Koudstaal, W., Sadoff, J., Barouch, D. H., Schuitemaker, H., Zahn, R.
10.1101/2021.01.30.428921 — Posted: 2021-01-30 Discussion: Onsite
Recombinant production of a functional SARS-CoV-2 spike receptor binding domain in the green algae Chlamydomonas reinhardtii
Berndt, A. J., Smalley, T. N., Ren, B., Badary, A., Sproles, A., Fields, F., Torres-Tiji, Y., Heredia, V., Mayfield, S. P.
10.1101/2021.01.29.428890 — Posted: 2021-01-30
The evolutionary making of SARS-CoV-2
Iruegas Lopez, R., Dosch, J., Sikora, M., Hummer, G., Covino, R., Ebersberger, I.
10.1101/2021.01.29.428808 — Posted: 2021-01-29
Information retrieval in an infodemic: the case of COVID-19 publications
Ferdowsi, S., Borissov, N., Kashani, E., Vicente Alvarez, D., Copara, J., Gouareb, R., Amini, P., Teodoro, D.
10.1101/2021.01.29.428847 — Posted: 2021-01-29
Recombination and low-diversity confound homoplasy-based methods to detect the effect of SARS-CoV-2 mutations on viral transmissibility
Giorgi, E. E., Bhattacharya, T., Fischer, W. M., Yoon, H., Abfalterer, W., Korber, B.
10.1101/2021.01.29.428535 — Posted: 2021-01-29
Development of spike receptor-binding domain nanoparticle as a vaccine candidate against SARS-CoV-2 infection in ferrets
Kim, Y.-I., Kim, D., Yu, K.-M., Seo, H. D., Lee, S.-A., Casel, M. A. B., Jang, S.-G., Kim, S., Jung, W., Lai, C.-J., Choi, Y. K., Jung, J. U.
10.1101/2021.01.28.428743 — Posted: 2021-01-29
Heterologous vaccination regimens with self-amplifying RNA and Adenoviral COVID vaccines induce superior immune responses than single dose vaccine regimens in mice
Spencer, A. J., McKay, P. F., Belij-Rammerstorfer, S., Ulaszewska, M., Bissett, C. D., Hu, K., Samnuan, K., Sharpe, H. R., Wright, D., Gilbride, C., Truby, A., Allen, E. R., Gilbert, S. C., Shattock, R. J., Lambe, T.
10.1101/2021.01.28.428665 — Posted: 2021-01-29
The SARS-CoV-2 Y453F mink variant displays a striking increase in ACE-2 affinity but does not challenge antibody neutralization
Bayarri-Olmos, R., Rosbjerg, A., Johnsen, L. B., Helgstrand, C., Bak-Thomsen, T., Garred, P., Skjoedt, M.-O.
10.1101/2021.01.29.428834 — Posted: 2021-01-29
Association of COVID-19 incidence with objectively and subjectively measured mental health proxies in the Austrian Football League: an epidemiological study
van der Zee-Neuen, A., Seymer, A., Schaffler-Schaden, D., Herfert, J., O Brien, J., Johansson, T., Kutschar, P., Ludwig, S., Stoeggl, T., Keeley, D., Flamm, M., Osterbrink, J.
10.1101/2021.01.27.21250527 — Posted: 2021-01-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).